Esketamine is neuroprotective against traumatic brain injury through its modulation of autophagy and oxidative stress via AMPK/mTOR-dependent TFEB nuclear translocation

2023/05/13 by Tang Yanbin, Yanbin Tang, Yufang Liu +5 · 26 citations
Medicine · Neuroscience · #Autophagy in Disease and Therapy #Cannabis and Cannabinoid Research #Neuroscience and Neuropharmacology Research

paper · doi:10.1016/j.expneurol.2023.114436

Cited by

• Metabolic dysfunction contributes to mood disorders after traumatic brain injury
• The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor-CaMKII pathway. [europepmc]
• Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options. [europepmc]
• [Lung-protective effect of esketamine combined with distal limb ischemic preconditioning in elderly patients undergoing thoracoscopic radical surgery for lung cancer: a randomized controlled trial in 160 cases]. [europepmc]
• Potential Molecular Mechanisms of Alcohol Use Disorder with Non-Coding RNAs and Gut Microbiota for the Development of Superior Therapeutic Application. [europepmc]
• Intricate Role of the Cyclic Guanosine Monophosphate Adenosine Monophosphate Synthase-Stimulator of Interferon Genes (cGAS-STING) Pathway in Traumatic Brain Injury-Generated Neuroinflammation and Neuronal Death. [europepmc]
• Effects of Esketamine Combined with Dexmedetomidine on Early Postoperative Cognitive Function in Elderly Patients Undergoing Lumbar Spinal Surgery: A Double-Blind Randomized Controlled Clinical Trial. [europepmc]
• Esketamine and neurocognitive disorders in adult surgical patients: a meta-analysis. [europepmc]
• Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. [europepmc]
• High-altitude hypoxia aggravated neurological deficits in mice induced by traumatic brain injury via BACH1 mediating astrocytic ferroptosis. [europepmc]
• Esketamine reduces postoperative depression in breast cancer through TREK-1 channel inhibition and neurotransmitter modulation. [europepmc]
• Temporal characterisation and electrophysiological implications of TBI-induced serine/threonine kinase activity in mouse cortex. [europepmc]
• Esketamine attenuates traumatic brain injury by modulating STAT3-mediated Glycolysis and immune responses. [europepmc]
• Efficacy and safety of esketamine in preventing perioperative neurocognitive disorders: a meta-analysis of randomized controlled studies. [europepmc]
• Effects of S-ketamine on recovery quality in elderly patients with impaired intrinsic capacity after total knee arthroplasty: a single-centre, randomised, double-blind, placebo-controlled study protocol. [europepmc]
• RNA signaling in skeletal muscle: the central role of microRNAs and exosomal microRNAs. [europepmc]
• The Impact of Esketamine on Depression: Targeting Oxidative Stress and Neuronal Apoptosis Through BDNF/TrkB/PI3K/AKT Pathway Activation. [europepmc]
• Ketamine's Role in Neuroinflammation and Neuroprotection Across Neurological and Psychiatric Disorders: A Narrative Review. [europepmc]
• Research Progress on Regulating Autophagy in Traditional Chinese Medicine for the Treatment of Traumatic Brain Injury. [europepmc]
• Advancements in the application of multimodal monitoring and machine learning for the development of personalized therapeutic strategies in traumatic brain injury. [europepmc]
• Toward a Unified Framework in Molecular Neurobiology of Alzheimer's Disease: Revisiting the Pathophysiological Hypotheses. [europepmc]
• The Effect of Opioid-Free Anesthesia with Esketamine on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic Surgery: A Prospective, Randomized, Controlled Trial. [europepmc]
• Esketamine as an opioid-sparing adjuvant for epidural labour analgesia: a randomised, double-blind trial evaluating postpartum depression. [europepmc]
• Esketamine Suppresses Astrocyte-Driven Neuroinflammation in Traumatic Brain Injury via the METTL5/c-Myc/PD-L1. [europepmc]
• Excitatory amino acid inhibitors in adults with acute moderate to severe traumatic brain injury: a systematic review and meta-analysis. [europepmc]
• Ketamine as a potential cognitive enhancer in neurological disorders: evidence from preclinical and clinical studies. [europepmc]